Microsoft has announced that Azure’s US central datacentre region is the first to receive a new artificial intelligence (AI) inference accelerator, Maia 200.

The Institute of Cancer Research has welcomed NICE’s recommendation of talazoparib in combination with enzalutamide for adults with metastatic prostate cancer, providing a new treatment option for ...